Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 6:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1033–1056 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Systemic Sclerosis, Constipation, Gastrointestinal Motility Disorder, Autonomic Dysfunction
Interventions: Transcutaneous Electrical Acustimulation (TEA), Sham-TEA; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Erectile Dysfunction
Interventions: AMS 700 IPP with MS Pump; Device
Lead sponsor: American Medical Systems; Industry
Eligibility: 21 Years and older · Male only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 7
States / cities: Indio, California • New Port Richey, Florida • Shreveport, Louisiana + 4 more

Conditions: Diabetes
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 417 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Sepsis, Burn Injury, Wound Healing, Critical Illness, Multiple Organ Dysfunction Syndrome
Interventions: Observational Cohort (No Intervention); Other
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Tampa, Florida • Atlanta, Georgia • Houston, Texas

Conditions: Meibomian Gland Dysfunction
Interventions: Tear Restore Mask; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 89 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Bradycardia, Sinus Node Dysfunction, Heart Block, Syncope, Cardiomyopathies, Heart Failure
Interventions: Implantation of the Tendril 2088 lead in the LBBA; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 221 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 5
States / cities: Jonesboro, Arkansas • Rancho Mirage, California • Pensacola, Florida + 2 more

Conditions: Metabolism
Interventions: Acute Resistance Exercise; Behavioral
Lead sponsor: Yuan Wen; Other
Eligibility: 18 Years to 30 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Cognitive Symptoms
Interventions: Not listed
Lead sponsor: Jay F. Piccirillo, MD; Other
Eligibility: 35 Years to 70 Years · Female only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Depression in Old Age, Psychotherapy, Mild Cognitive Impairment, Executive Dysfunction
Interventions: Engage; Behavioral
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Sphincter of Oddi Dysfunction, Abdominal Pain
Interventions: Not listed
Lead sponsor: Wisconsin Center for Advanced Research; Other
Eligibility: 18 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Cancer, Cognitive Impairment
Interventions: COPE +; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stroke, Cognitive Impairment, Executive Dysfunction, Cognitive Change, Cognitive Deficit
Interventions: Mobile or tablet-based gaming applications, Stroke-related educational videos; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Sellar/Parasellar Tumor, Smell Dysfunction
Interventions: Omega-3; Dietary Supplement
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Stanford, California • Atlanta, Georgia

Conditions: Healthy, Cognitive Impairment, Neurological Disorder
Interventions: Brain Network Activation (BNA™) technology; Device
Lead sponsor: ElMindA Ltd; Industry
Eligibility: 8 Years to 99 Years
Enrollment: 10,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 4
States / cities: La Jolla, California • Chicago, Illinois • Skokie, Illinois + 1 more

Conditions: Panic Disorder
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Premature Ejaculation
Interventions: IX-01 400 mg, Placebo, IX-01 800 mg, IX-01 1200 mg; Drug
Lead sponsor: Ixchelsis Limited; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 29
States / cities: Mobile, Alabama • Chandler, Arizona • Mesa, Arizona + 25 more

Conditions: COVID-19, Olfactory Disorder, Anosmia, Hyposmia, Parosmia
Interventions: Gabapentin gelatin capsules 300mg, Placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cognitive Decline
Interventions: Not listed
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 70 Years to 79 Years
Enrollment: 2,632 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2002
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Memphis, Tennessee

Conditions: Delirium, Cognitive Dysfunction
Interventions: Electroencephalogram (EEG); Diagnostic Test
Lead sponsor: Stanford University; Other
Eligibility: 55 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pelvic Floor Disorders, Pelvic Pain
Interventions: Diazepam, Placebo; Drug
Lead sponsor: Raymond Foster; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Neurogenic Bladder Dysfunction
Interventions: Genital Nerve Stimulation; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Syracuse, New York • Cleveland, Ohio

Conditions: Alzheimers Disease, Mild Cognitive Impairment
Interventions: 5 Sessions of Split-belt Treadmill-based Locomotor Adaptation; Other
Lead sponsor: Emory University; Other
Eligibility: 50 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Stroke With Hemiparesis
Interventions: Botulinum Toxin commonly known as BOTOX®, Placebo; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Age-Related Memory Disorders
Interventions: Transdermal nicotine patch, Placebo transdermal patch; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 55 Years to 90 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Durham, North Carolina • Burlington, Vermont

Search by objective public record fields.

Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis

Evaluation of the 2005 AMS (American Medical System) IPP (Inflatable Penile Prosthesis)

DHS MIND Metabolomics

Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1

The Effect of Warm Compress Therapy Using the TearRestore Eyelid Warming Mask on Meibomian Gland Function

LBBAP Data Collection Registry

Training Induced Muscle Exosome Release

Chemotherapy-Induced Cognitive Impairment

Engage for Late-Life Depression and Comorbid Executive Dysfunction

Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction

Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention

Gaming Apps Post-Stroke

Omega-3 Supplementation for Smell Dysfunction

Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology

Neurobiological Mechanisms in Panic Disorder

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)

Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction

Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline

Stanford-Lucidify EEG Delirium Study

Vaginal Diazepam for the Treatment of Female Pelvic Pain

Chronic Electrical Stimulation to Reduce Bladder Hyperreflexia

Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease

Study of Botulinum Toxin and Recovery of Hand Function After Stroke

Nicotine Treatment of Mild Cognitive Impairment (MCI)